Wojcicki was outsmarted by the board, see [Bankruptcy Was Good for 23andMe](https://www.bloomberg.com/opinion/newsletters/2025-06-05/bankruptcy-was-good-for-23andme):

> You never really want to be on a board of directors where the clever strategic move is to file for bankruptcy, but sometimes it really is the right move.



Scroogey

Stacker_Stocks

> Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals, the company announced Friday. 

> TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research Services business lines as well as telehealth subsidiary Lemonaid Health. It’s a big win for Wojcicki, who stepped down from her role as CEO when 23andMe filed for Chapter 11 bankruptcy protection in March.


Back again where it was. She just couldn't let it go. The DNAs, the data, the name "23andme" is too dear for her to let go. 